Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.

Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol HSDT
- Company Helius Medical Technologies, Inc.
- Price $3.87
- Changes Percentage -5.56
- Change -0.2277
- Day Low $3.72
- Day High $3.89
- Year High $24
- Year Low $3.23
- Market Cap $1,853,498
- Price Avg 50 EMA (D) $4.78
- Price Avg 200 EMA (D) $8.15
- Exchange NASDAQ
- Volume 57,553
- Average Volume 15,380
- Open $3.75
- Previous Close $4.1
- EPS -26.4
- PE -0.13
- Earnings Announcement 2025-08-11 10:00:00
- Shares Outstanding $528,062
Company brief: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT )
- Healthcare
- Medical - Devices
- Mr. Dane Carl Andreeff
- https://heliusmedical.com
- US
- N/A
- 06-27-2014
- US42328V8019
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.